跳至主要内容
临床试验/DRKS00014299
DRKS00014299已完成未知

Subthreshold laser treatment with Endpoint Management in central serous chorioretinopathy

Augenklinik der Ludwig-Maximilians Universität München0 个研究点目标入组 39 人开始时间: 2018年4月5日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
39

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Age = 18 years
  • BCVA better than 0,05
  • Subject is generally healthy and able to give informed consent.
  • Diagnosis of CRCS confirmed by retinal specialist
  • Normal findings in the medical history unless the investigator considers an abnormality to be clinically irrelevant

排除标准

  • Any other macular disease with possibility of developing subretinal fluid: vitreomacular traction syndrome, epiretinal membranes, age-related macular degeneration, diabetic retinopathy, choroidal neovascularization, uveitis
  • Ocular surgery for 6 months preceding the study
  • Previous intravitreal injections of anti-VEGF, steroids within 6 months preceding the study
  • Previous macular laser treatment or photodynamic therapy within 3 months preceding the study
  • Present ocular infection or clinically significant inflammation
  • Patient is not able to cooperate or has any other medical or psychological condition that prohibits him from regular follow-up
  • Kidney failure or dialysis
  • Allergy to fluorescein
  • Participation in a clinical trial in the 30 days preceding the study
  • Planned intraocular surgery within one 12 months
  • Women: Pregnancy or currently breast-feeding
  • History of systemic or topical corticosteroid use within last 6 months

研究者

发起方
Augenklinik der Ludwig-Maximilians Universität München

相似试验

Subthreshold laser treatment with Endpoint... | 临床试验